Caliber 3This page contains information on Caliber 3 for veterinary use.
The information provided typically includes the following:
- Caliber 3 Indications
- Warnings and cautions for Caliber 3
- Direction and dosage information for Caliber 3
Caliber 3This treatment applies to the following species:
Clostridium Perfringens Types C&D Toxoid
Caliber 3 Indications
This product has been shown to be effective for the vaccination of healthy sheep and cattle, including pregnant and lactating cows, against Clostridium perfringens types C and D. This product was licensed prior to the requirement to establish a minimum age for use. The duration of immunity has not been determined. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.
Although Cl. perfringens type B is not a significant problem in the U.S.A., immunity may be provided against the beta and epsilon toxins elaborated by Cl. Perfringens type B. This immunity is derived from the combination of type C (beta) and type D (epsilon) fractions.
Directions and dosage: Mix well before use. Using aseptic technique, inject 2 mL subcutaneously. Repeat in 21 to 28 days. Contact your veterinarian or the manufacturer for information on revaccination frequency.
PrecautionsStore out of direct sunlight at 35-46°F (2-8°C). Do not freeze. Do not mix with other products. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. In case of anaphylactoid reaction, administer epinephrine. This product has not been tested in pregnant sheep. In case of human exposure, contact a physician.
Boehringer Ingelheim Animal Health USA Inc., St. Joseph, MO 64506
Phone: 1 (888) 637-4251
250 Doses/500 mL
3239 SATELLITE BLVD., DULUTH, GA, 30096
|Every effort has been made to ensure the accuracy of the Caliber 3 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2022 Animalytix LLC. Updated: 2021-11-29